Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Subscribe To Our Newsletter
BOARD TURNS DOWN PROPOSAL TO PROVIDE ADDITIONAL FUNDING FOR GRANTS IN BOSNIA AND HERZEGOVINA
GFO Issue 293

BOARD TURNS DOWN PROPOSAL TO PROVIDE ADDITIONAL FUNDING FOR GRANTS IN BOSNIA AND HERZEGOVINA

Author:

David Garmaise

Article Type:
News

Article Number: 5

A TB grant and HIV grant are affected

ABSTRACT The Global Fund Board has declined to approve extensions for a TB and an HIV grant to Bosnia and Hercegovina. No reasons for the decision have been made public.

GFO has learned that the Global Fund Board has turned down a recommendation to provide additional funding for a TB grant and an HIV grant in Bosnia and Herzegovina.

There has been no public announcement of the Board decision. Nor has the Global Fund made public any details concerning the amounts involved, the rationale for the recommendation, or the reasons why the recommendation was not approved.

There are two active grants in Bosnia and Herzegovina: a TB grant (BIH-T-UNDP) and an HIV grant (BIH-910-G03-H). The principal recipient for both grants is UNDP. According to the latest grant performance reports, the TB grant, which had a value of $16.4 million, was scheduled to end on 30 June 2016. It is rated A2. The HIV grant, which was worth € 21.8 million, was set to end of 30 September 2016. It is rated A1.

GFO has so far not been able to obtain additional information from the Global Fund Secretariat or information that we can publish from UNDP. No one seems to want to comment on the record.

We will attempt to provide more information in a follow-up article.

Leave a reply

  • Anonymous comments (0)
  • Facebook Comments

Your email address will not be published.

Aidspan

Categories*

Loading
Aidspan

Categories*

Loading